Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Melanoma Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00655655
What this trial is testing

Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors

Who this might be right for
GastrinomaGlucagonomaInsulinoma+17 more
Mayo Clinic 96
Early research (Phase 1)Study completedNCT00091104
What this trial is testing

Cyclophosphamide and Fludarabine Followed by Vaccine Therapy, Gene-Modified White Blood Cell Infusions, and Aldesleukin in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
National Institutes of Health Clinical Center (CC) 136
Testing effectiveness (Phase 2)UnknownNCT02617849
What this trial is testing

Pembrolizumab With Carboplatin/Paclitaxel in Patients With Metastatic Melanoma

Who this might be right for
Metastatic Malignant Melanoma
Wilson Miller 30
Testing effectiveness (Phase 2)Study completedNCT00024011
What this trial is testing

PS-341 in Treating Patients With Metastatic Malignant Melanoma

Who this might be right for
Recurrent MelanomaStage IV Melanoma
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06708455
What this trial is testing

Phase 2b of RAPA-201 Cell Therapy in Post-PD-(L)-1 Melanoma

Who this might be right for
Malignant Melanoma With MetastasisMalignant MelanomaMalignant Melanoma Stage IIIc+1 more
Rapa Therapeutics LLC 65
Early research (Phase 1)Study completedNCT00223899
What this trial is testing

A Trial to Evaluate the Safety of Intratumoral VCL-IM01 Followed by Electroporation in Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Vical 26
Large-scale testing (Phase 3)Ended earlyNCT01006252
What this trial is testing

Tasisulam-sodium Versus Paclitaxel as Treatment for Metastatic Melanoma

Who this might be right for
Melanoma
Eli Lilly and Company 336
Testing effectiveness (Phase 2)Ended earlyNCT02054520
What this trial is testing

Immunotherapy Study for Patients With Stage IV Melanoma

Who this might be right for
Stage IV MelanomaMetastatic Melanoma
NewLink Genetics Corporation 47
Testing effectiveness (Phase 2)Study completedNCT00085423
What this trial is testing

Cyclophosphamide, Fludarabine, and High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Dartmouth-Hitchcock Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT02306850
What this trial is testing

Neoadjuvant Pembrolizumab for Unresectable Stage III and Unresectable Stage IV Melanoma

Who this might be right for
Unresectable Malignant NeoplasmMelanomaMetastatic Melanoma+2 more
St. Louis University 10
Testing effectiveness (Phase 2)Study completedNCT03850691
What this trial is testing

Radiation and Combination Immunotherapy for Melanoma

Who this might be right for
Metastatic Melanoma
Masonic Cancer Center, University of Minnesota 4
Testing effectiveness (Phase 2)Ended earlyNCT00496223
What this trial is testing

A Phase I/II Study of Sunitinib and Dacarbazine

Who this might be right for
Melanoma
H. Lee Moffitt Cancer Center and Research Institute 11
Early research (Phase 1)Ended earlyNCT07076550
What this trial is testing

A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of Study Drug A9-3408 in Subjects With Metastatic Melanoma

Who this might be right for
Melanoma MetastaticUveal Melanoma, MetastaticMucosal Melanoma
Alpha-9 Oncology USA Inc. 5
Testing effectiveness (Phase 2)UnknownNCT03715985
What this trial is testing

Personalized Neo-antigen Vaccine in Advanced Solid Tumors (NeoPepVac)

Who this might be right for
Malignant Melanoma, MetastaticNon Small Cell Lung Cancer MetastaticBladder Urothelial Carcinoma, Metastatic
Herlev Hospital 12
Large-scale testing (Phase 3)Study completedNCT01515189
What this trial is testing

Phase 3 Trial in Subjects With Metastatic Melanoma Comparing 3 mg/kg Ipilimumab Versus 10 mg/kg Ipilimumab

Who this might be right for
Melanoma
Bristol-Myers Squibb 831
Testing effectiveness (Phase 2)Ended earlyNCT00421317
What this trial is testing

Imatinib in Adult Patients With Metastatic Ocular Melanoma

Who this might be right for
Melanoma
Centre Oscar Lambret 13
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07807878
What this trial is testing

Trial of Temozolomide in BAP1 Mutated Patients With Advanced or Metastatic Cutaneous Melanoma

Who this might be right for
Cutaneous Melanoma
Assistance Publique Hopitaux De Marseille 28
Early research (Phase 1)Study completedNCT03415126
What this trial is testing

ASN007 in Patients With Advanced Solid Tumors

Who this might be right for
CancerMalignancyNeoplasia+16 more
Asana BioSciences 49
Early research (Phase 1)Study completedNCT05003622
What this trial is testing

Phase 1 Safety Study of Encorafenib in Chinese Patients With Advanced Metastatic BRAF V600E Mutant Solid Tumors

Who this might be right for
BRAF V600E Unresectable or Metastatic MelanomaBRAF V600E Metastatic NSCLCMelanoma
Pierre Fabre Medicament 3
Testing effectiveness (Phase 2)UnknownNCT03313323
What this trial is testing

Uptake and Biodistribution of 89Zirconium-labeled Ipilimumab in Ipilimumab Treated Patients With Metastatic Melanoma

Who this might be right for
Melanoma
Amsterdam UMC, location VUmc 29
Next Page